CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,990,220 | +512.1% | 4,070 | -92.7% | 1.44% | +224.8% |
| Q1 2023 | $1,958,886 | -18.1% | 55,666 | -54.0% | 0.44% | +130.1% |
| Q2 2021 | $2,393,000 | -19.0% | 120,895 | -4.8% | 0.19% | +94.9% |
| Q1 2021 | $2,954,000 | -62.3% | 127,000 | -66.3% | 0.10% | -71.3% |
| Q4 2020 | $7,834,000 | -76.6% | 377,000 | -75.6% | 0.34% | -85.8% |
| Q3 2020 | $33,481,000 | +221.1% | 1,546,600 | +74.9% | 2.42% | +209.1% |
| Q1 2020 | $10,427,000 | – | 884,400 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |